Aaron C. Logan, MD PhD¹, Alex F. Herrera, MD², Christine E. Ryan³, Andrew R. Rezvani, MD⁴, Katherine A. Kong, PhD^5*, Malek Faham, MD, PhD⁵, Gheath Alatrash, DO, PhD⁶, Jeffrey J. Molldrem, MD^6*, Rachel L. Sargent, MD^7*, Edwin P. Alyea, MD⁸, Vincent T. Ho, MD⁸, Jennifer R. Brown, MD, PhD⁹, Jerome Ritz, MD¹⁰ and David B. Miklos, MD, PhD³

¹Department of Medicine, Division of Hematology and Blood and Marrow Transplantation, University of California, San Francisco, San Francisco, CA
²Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA
³Department of Medicine, Division of Blood and Marrow Transplantation, Stanford University Medical Center, Stanford, CA
⁴Division of Blood & Marrow Transplantation, Stanford University, Stanford, CA
⁵Adaptive Biotechnologies Corp., South San Francisco, CA
⁶Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁹Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
¹⁰Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA

Kazuyoshi Ishii, MD, MPH, PhD¹, Shosaku Nomura, MD, PhD¹, Shinya Fujita, MD, PhD^1*, Atushi Satake, MD, PhD^2*, Tomoki Ito, MD, PhD^1*, Yuta Katayama, MD, PhD^3*, Taiichi Kyo, MD, PhD^4*, Shuichi Ota, MD, PhD⁵, Masanori Seki, MD, PhD^6*, Shigeru Chiba, MD, PhD⁶, Yoshinobu Maeda, MD, PhD⁷, Mitsune Tanimoto, MD, PhD⁷, Takayuki Ikezoe, MD. PhD⁸, Hideo Yagi, MD, PhD⁹, Kunio Hayashi, MD, PhD¹⁰, Yoji Ishida, M.D., Ph.D.¹¹, Naohito Fujishima, MD, PhD¹², Kenichi Sawada, M.D., Ph.D.¹³, Masaya Okada, MD, PhD^14* and Hiroyasu Ogawa, MD, PhD¹⁴

¹First Department of Internal Medicine, Kansai Medical University, Osaka, Japan
²First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan
³Internal Medicine, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan
⁴Department of Internal Medicine, Hiroshima Red Cross and Atomic Bomb Survivals Hospital, Hiroshima, Japan
⁵Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
⁶Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
⁷Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
⁸Department of Hematology and Respiratory Medicine, Kochi University School of Medicine, Nankoku, Japan
⁹Department of Hematology, Kinki University School of Medicine Nara Hospital, Ikoma, Japan
¹⁰Department of Hematology, Meiwa General Hosipital, Nishinomiya, Japan
¹¹Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan
¹²Department of Hematology, Nephrology and Rheumatology, Akita University School of Medicine, Akita, Japan
¹³Department of Hematology, Nephrology and Rheumatology, Akita University, Akita, Japan
¹⁴Department of Hematology, Hyogo College of Medicine, Nishinomiya, Japan

Betul Oran, MD¹, Jeffrey L. Jorgensen, MD, PhD², Sa A. Wang, MD^3*, David Marin, MD, DM, MSc^1*, Uday R. Popat, MD¹, Julianne Chen^1*, Stefan O. Ciurea, MD¹, Sairah Ahmed, MD¹, Qaiser Bashir, MD¹, Katayoun Rezvani, M.D., PhD¹, Elizabeth J. Shpall, MD¹, Partow Kebriaei, MD⁴ and Richard E. Champlin, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
³Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Nicolaus Kroeger¹, Anita Badbaran^2*, Tatjana Zabelina, M.D.^2*, Maximilian Christopeit, M.D.^2*, Christine Wolschke, M.D.^2*, Francis Ayuk, M.D.^1*, Axel R. Zander, Professor¹, Haefaa Alchalby, M.D.^2*, Ulrike Bacher^3*, Ioanna N Triviai, PhD^2* and Boris Fehse, PhD^2*

¹University Medical Center Hamburg-Eppendorf, Hamburg, Germany
²Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
³University Hospital Göttingen, Göttingen, Germany

Gesine Bug, MD^1*, Andreas Burchert, MD², Eva-Maria Wagner, MD^3*, Nicolaus Kroeger, MD⁴, Zuzana Jedlickova, MD^1*, Saskia Gueller, MD¹, Stephan Metzelder, MD^5*, Andrea Wolf^1*, Peter Bader, MD⁶, Sabine Huenecke, PhD^6*, Hubert Serve⁷ and Oliver G. Ottmann, MD^8*

¹Dept. of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Frankfurt/Main, Germany
²Department of Hematology, Oncology and Immunology, Universitätsklinikum Giessen und Marburg, Marburg, Germany
³Third Department of Medicine - Hematology, Oncology and Pneumology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
⁴Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany
⁵Dept. Hematology, Oncology, Immunology, Philipps University of Marburg, Medical Center of the University Giessen and Marburg, Marburg, Germany
⁶Division for Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany
⁷Dept. of Medicine II, Hematology/Oncology, Goethe University Hospital Frankfurt, Frankfurt/Main, Germany
⁸Department of Haematology, Cardiff University, Cardiff, United Kingdom

Issa F. Khouri¹, Elias Jabbour², Rima M Saliba, Ph.D^1*, Celina Ledesma^1*, Jan A Burger, MD, PhD², Susan O'Brien, MD³ and Alison M Gulbis^4*

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³University of California - Irvine, Orange, CA
⁴Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX

Noga Shem-Tov, MD^1*, Francesco Saraceni, MD^1*, Ivetta Danylesko, MD^1*, Ronit Yerushalmi, MD¹, Arnon Nagler, MD, MSc¹ and Avichai Shimoni, MD^2*

¹Hematology Division and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Tel-Aviv, Israel
²Hematology Division, Chaim Sheba Medical Center and Tel Aviv University, Tel-Hashomer, Ramat-Gan, Israel

Piyanuch Kongtim, MD^1,2*, Uday R. Popat, MD², Antonio M. Jimenez, MD³, Sameh Gabella^4*, Riad O. El Fakih, MD,^2*, Gabriela Rondon, MD², Julianne Chen^2*, Carlos E. Bueso-Ramos, MD⁵, Gautam Borthakur, MD⁶, Naveen Pemmaraju^7*, Guillermo Garcia-Manero, MD⁸, Hagop M. Kantarjian, MD⁶, Amin M. Alousi, MD², Chitra M. Hosing, MD², Paolo Anderlini, MD², Issa F. Khouri², Partow Kebriaei, MD², Borje S. Andersson, MD, PhD², Betul Oran, MD², Katayoun Rezvani, M.D., PhD⁹, David Marin, MD, DM, MSc^2*, Elizabeth J. Shpall, MD², Richard E. Champlin, MD² and Stefan O. Ciurea, MD²

¹Division of Hematology Department of Internal Medicine Faculty of Medicine Thammasat University, Pathumthani, Thailand
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Texas MD Anderson Cancer Center, 1Departments of 1Stem Cell Transplantation and Cellular Therapy, Houston
⁴Departments of 1Stem Cell Transplantation and Cellular Therapy, Houston
⁵The University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston
⁶Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston
⁸Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX
⁹Stem Cell and Cellular Therapy, MD Anderson Cancer Center, Houston, TX

Jack Stuart^1*, Richard Szydlo, PhD^2*, Jane F. Apperley, MD³, Jeannie Todd, PhD^4* and Nina Salooja, DM, FRCP, FRCPath^5*

¹Imperial College, London, United Kingdom
²Centre for Haematology, Imperial College London, London, United Kingdom
³Haematology Department, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
⁴Hammersmith hospital, London, United Kingdom
⁵Haematology, Hammersmith Hospital, London, United Kingdom

Kwai Han Yoo^1*, Jinhyun Cho^1*, Haa-Na Song^1*, Ki Sun Jung^1*, Juhee Cho^2*, Young Rok Do³, Seok Jin Kim, MD, PhD⁴, Kihyun Kim⁵, Chul Won Jung⁶ and Jun Ho Jang, MD, PhD^6*

¹Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
²Cancer Education Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
³Dongsan Medical Center, Keimyung University, Daegu, South Korea
⁴Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
⁵Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
⁶Samsung Medical Center, Seoul, South Korea

Matthew P. Mulé, BS^1*, Gabriel N. Mannis, MD², Jerald P. Radich, MD^3*, Brent L. Wood, MD PhD^3*, Nestor R. Ramos, MD^1*, Catherine E. Lai, MD^1*, Michael Flanders, BA^2*, Charalambos Andreadis, MD, MSCE², Lloyd E. Damon, MD^2*, Aaron C. Logan, MD PhD², Thomas G. Martin, MD² and Christopher S. Hourigan, MD PhD¹

¹Myeloid Malignancies Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
²Department of Medicine, Division of Hematology and Blood and Marrow Transplantation, University of California, San Francisco, San Francisco, CA
³Fred Hutchinson Cancer Research Center, Seattle, WA

Rachel Phelan, MD, MPH¹, Paul J Orchard, MD^2*, Margaret Semrud-Clikeman, PhD^3*, Nicholas Smiley^3* and Weston P Miller IV, MD²

¹Pediatric Hematology, Oncology and BMT, University of Minnesota, Minneapolis, MN
²Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
³Pediatric Clinical Behavioral Neuroscience, University of Minnesota, Minneapolis, MN

Qifa Liu, MD¹, Meiqing Wu^1*, Jing Sun, MD², Yu Zhang, MD^1*, Fen Huang^1*, Hongsheng Zhou^1*, Zhiping Fan^1*, Li Xuan^1*, Guopan Yu^1*, Xutao Guo^1*, Min Dai^1* and Ru Feng, MD¹

¹Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
²Department of Hematology, NanFang Hospital, Southern Medical University, Guangzhou, China

Jeremy Delage^1*, Stephane Vigouroux^1*, Reza Tabrizi¹, Catherine Mohr^1*, Pascal Turlure, MD^2* and Noel Milpied³

¹Service d’Hematologie Clinique et Therapie Cellulaire, CHU de Bordeaux, Pessac, France
²Service d’Hematologie Clinique et Therapie Cellulaire, Centre Hospitalier Universitaire de Limoges, Limoges, France
³Service d’Hematologie Clinique et Therapie Cellulaire, CHU Haut-Lévêque, Bordeaux, France

Michael Scordo, MD^1*, Valkal Bhatt, PharmD^1*, Meier Hsu, MS^2*, Antonio M. Omuro, MD^3*, Matthew J. Matasar, MD, MS⁴, Lisa DeAngelis, MD^5*, Parastoo B. Dahi, MD¹, Craig H. Moskowitz, MD⁶, Sergio A. Giralt, MD¹ and Craig S. Sauter, MD¹

¹Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Medicine, Lymphoma and Adult BMT Services, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Neurology, Memorial Sloan Kettering, New York, NY
⁶Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Michael J Shipton, MBChB, BSc^1*, David JM Routledge, MRCP^2*, Neil Bodagh, MBChB, BSc^3*, James Cavet, FRCPath^1*, Eleni Tholouli³, Samar Kulkarni, FRCPath² and Simon DJ Gibbs⁴

¹Department of Haematology, The Christie NHS Foundation Trust, Manchester, United Kingdom
²The Christie NHS Foundation Trust, Manchester, United Kingdom
³Department of Haematology, Central Manchester NHS Foundation Trust, Manchester, United Kingdom
⁴Department of Clinical Haematology, Monash University Eastern Health Clinical School, Box Hill, Australia

Veronica Gonzalez De La Calle, MD^1*, Eduardo Sobejano^2*, Julio Davila, MD^3*, Enrique M Ocio^4*, Noemi Puig, MD, PhD^5*, Norma C Gutierrez^6*, Ramon Garcia-Sanz, MD PhD^7*, Alfonso Garcia de Coca, MD, PhD^8*, Jose Mariano Hernandez, MD^9*, Roberto Hernandez, MD^10*, Abelardo Bárez, MD^11*, Jose M. Alonso, MD^12*, Carmen Aguilera, MD^13*, Fernando Escalante, MD^14*, Guillermo Martin^15*, Rosa Lopez^15*, Pilar De la Fuente^16*, Jorge Labrador, MD^17*, Carlos Aguilar, MD^18* and Maria-Victoria Mateos, MD, PhD⁴

¹University Hospital of Salamanca, SALAMANCA, Spain
²Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
³Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
⁴Complejo Asistencial Universitario de Salamanca (IBSAL) y Centro de Investigación del Cáncer (IBMCC-CSIC). Universidad de Salamanca, Salamanca, Spain
⁵Instituto Biosanitario de Salamanca (IBSAL) and Cancer Research Centre (Instituto de Biología Molecular y Celular del Cáncer; CSIC-USAL), Salamanca, Spain
⁶Hospital Universitario de Salamanca. Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
⁷Department of Hematology, Hospital Universitario de Salamanca, IBSAL; IBMCC (USAL-CSIC),, Salamanca, Spain
⁸Hospital Clínico Universitario de Valladolid, Valladolid, Spain
⁹Hospital General de Segovia, Segovia, Spain
¹⁰Complejo Asistencial de Zamora, Zamora, Spain
¹¹Department of Hematology, Hospital Nuestra Señora de Sonsoles, Avila, Spain
¹²Hospital Rio Carrión de Palencia, Palencia, Spain
¹³Hospital Río Carrión de Palencia, Palencia, Spain
¹⁴Hematology Department, Complejo Hospitalario de León, León, Spain
¹⁵Hospital Virgen del Puerto de Plasencia, Spain, Plasencia, Spain
¹⁶Complejo Asistencial de Burgos, Burgos, Spain
¹⁷Hospital Universitario de Burgos, Burgos, Spain
¹⁸Department of Hematology, Hospital de Soria, Soria, Spain

Sabine Amah, MD^1*, Catherine Poirot, MD, PhD^2*, Sylvie Chevret^3*, Mony Fahd, MD^4*, Karima Yakouben, MD^5*, Marie Ouachee, MD^4*, Jean Claude Carel, MD, PhD^5,6*, Andre Baruchel, MD⁷ and Jean-Hugues Dalle, MD, PhD^6,8

¹Hematology-immunology Department, Robert-Debre Hospital, Assistance Publique-Hopitaux de Paris, Paris, France
²Pierre et Marie Curie University, Paris, France
³Biostatistics department, Hôpital Saint-Louis, Paris, France
⁴Hôpital Robert Debre, APHP, Paris, France
⁵Robert Debre Hospital, AP-HP, Paris, France
⁶Paris 7 - Paris Diderot University, Paris, France
⁷Pediatric Hematology, Robert Debré Hospital - APHP and University Paris Diderot, Paris, France
⁸Pediatric Hematology Immunology, Robert Debre Hospital, Paris, France

Samuel Romero Sr.^1*, Juan Montoro Sr.^1*, Jaime Sanz, MD,^2,3, Marta Guinot Sr.^1*, Empar Mayordomo Sr.^1*, Rafael López Sr.^1*, Isabel Beneyto Sr.^1*, Luis Almenar Sr.^1*, Amparo Soler Sr.^1*, Guillermo Sanz, MD, PhD^4,5,6 and Miguel Ángel Sanz, MD, PhD⁷

¹La Fe Hospital, Valencia, Spain
²Hospital Universitario la Fe, Valencia, Spain
³Grupo Español de Trasplante Hematopoyetico, GETH, Madrid, Spain
⁴Dept. Hematology, Hospital Universitario La Fe, Valencia, Spain
⁵Hospital Universitario La Fe, Spanish MDS Cooperative Group, Valencia, Spain
⁶GESMD, Valencia, Spain
⁷Hematology, Hospital Universitari i Politecnic La Fe, Valencia, Spain

Robert Collins, MD¹, Hagop M. Kantarjian, MD², Farhad Ravandi, MD², Jenny Chen, MD Phd^3*, Meghan Macaraeg, BS^4*, Vinoo Urity, MS^3*, Blake Pond, MS^5*, Abhijit Ramachandran, MS^6* and Jorge E. Cortes, MD⁷

¹University of Texas Southwestern Medical Center, Dallas, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³AROG Pharmaceuticals, Dallas
⁴AROG Pharmaceuticals, Dallas, TX
⁵Clinical Research Manager, University of Texas Southwestern Medical Center, Dallas, TX
⁶Clinical Operations, AROG Pharmaceuticals, Dallas, TX
⁷Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Narendranath Epperla, MD¹, Namrata Shah, MD^1*, Kristin Richardson, MD^2*, Jonathan Kapke, DO³, George Carrum, MD⁴, Parameswaran Hari, MD, MRCP, MS⁵, Mehdi Hamadani, MD¹, Sai Ravi Pingali, MD⁶, Reem Karmali, MD, MS⁷ and Timothy S. Fenske, MD¹

¹Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
²Department of Medicine, Rush Medical Center, Chicago, IL
³Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX
⁵Medical College of Wisconsin, Milwaukee, WI
⁶Division of Hematology & Oncology, Houston Methodist Cancer Center, Houston, TX
⁷Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, IL

Panagiotis Tsirigotis^1*, Ronit Yerushalmi, MD², Kostantinos Gkirkas^3*, Noga Shentov^4*, Ivetta Danylesko, MD^2*, Maria Stamouli, MD^3*, Abraham Avigdor, MD⁴, Mohamad Mohty, MD⁵, Avichai Shimoni^4* and Arnon Nagler, MD, MSc⁶

¹ATTIKO General University Hospital, Athens, Greece
²Hematology Division and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Tel-Aviv, Israel
³2nd Department of Internal Medicine, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece
⁴Hematology Division and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Tel Aviv, Israel
⁵Department of Hematology and Cell Therapy, Saint Antoine Hospital, Paris, France
⁶Hematology Division, Chaim Sheba Medical Center and Tel Aviv University, Tel-Hashomer, Ramat-Gan, Israel

Maria Teresa Lupo-Stanghellini, MD^1*, Andrea Assanelli, MD^1*, Alessia Orsini, MD^1*, Raffaella Greco, MD^2*, Fabio Giglio, MD^1*, Sara Mastaglio, MD^1*, Mara Morelli, MD^1*, Francesca Pavesi, MD^1*, Elisa Sala, MD^1*, Margherita Brambilla, RN^1*, Simona Piemontese, MD^1*, Elisabetta Xue, MD^1*, Luca Vago, MD, PhD², Carlo Messina, MD^1*, Serena Camilla Dalto, MD^1*, Francesca Lorentino, MD^1*, Lucia Malabarba, MD^1*, Ambra Malerba, BSc^1*, Magda Marcatti, MD^1*, Elena Guggiari, MD^1*, Sarah Marktel, MD^1*, Matteo G Carrabba, MD^2*, Francesca Lunghi, MD^1*, Massimo Bernardi, MD^2*, Chiara Bonini, MD³, Consuelo Corti, MD^1*, Jacopo Peccatori, MD^1* and Fabio Ciceri, MD^4*

¹Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
²Unit of Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milano, Italy
³Experimental Hematology Unit, San Raffaele Hospital Scientific Institute, Milan, Italy
⁴Hematology and Bone Marrow Transplantation Unit, San Raffaele Hospital Scientific Institute, Milan, Italy

Sarmiento Mauricio, MD PhD^1,2*, Ildefonso Espigado, MD, PhD³, Rocio Parody, M.D.^4,5*, Francisco Marquez, NR^6*, Jose Falantes, M.D.^7*, Teresa Caballero, PhD^8*, Cristina Calderon, MD^9*, Magdalena Carmona, MD PhD^6*, Jose Lopez, MD PhD^10* and Jose A. Perez-Simon, M.D., PhD⁵

¹Pontificia Universidad Católica de Chile, Santiago, Chile
²Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS / CSIC), Sevilla, Spain
³Hospital Universitario Virgen del Rocío, Sevilla, Sevilla, Spain
⁴Hematology Unit, University Hospital Virgen del Rocío, Seville (Spain), Seville, Spain
⁵Dept. of Hematology, Hospital Universitario Virgen del Rocío, Sevilla, Spain
⁶Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS / CSIC). Sevilla, España., Seville, Spain
⁷Department of Hematology, Hospital Universitario Virgen del Rocío, Sevilla, Spain
⁸Department of hematology/Institute of Biomedicine. Hospital Virgen of Rocío, Seville, Spain
⁹Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS / CSIC), Seville, Spain
¹⁰Departement of cardiology, Hospital Universitario Virgen del Rocío. Sevilla, España, Seville, Spain